Slate Stone Wealth, LLC Bristol Myers Squibb CO Transaction History

Slate Stone Wealth, LLC

$996 Million
Q1 2025

A detailed history of Slate Stone Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 4,815 shares of BMY stock, worth $223,175. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,815

Previous 3,915 22.99%

Holding current value

$223,175

Previous $221,000 33.03%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$53.9 - $63.11 $48,510 - $56,799	900 Added 22.99%	4,815 $294,000
Q4 2024 Feb 10, 2025	SELL	$51.92 - $59.94 $6,126 - $7,072	-118 Reduced 2.93%	3,915 $221,000
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $159,948 - $208,707	4,033 New	4,033 $209,000
Q1 2024 Apr 26, 2024	BUY	$47.98 - $54.4 $47 - $54	1 Added 0.02%	5,295 $287,000
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $24,143 - $28,809	-498 Reduced 8.6%	5,294 $272,000
Q3 2023 Oct 12, 2023	SELL	$57.89 - $64.73 $31,202 - $34,889	-539 Reduced 8.51%	5,792 $336,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $51,159 - $56,804	-803 Reduced 11.26%	6,331 $405,000
Q1 2023 Aug 08, 2023	SELL	$65.71 - $74.53 $65 - $74	-1 Reduced 0.02%	6,330 $439,000
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $333,840 - $395,313	-4,875 Reduced 40.59%	7,134 $513,000
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $0 - $76	1 Added 0.01%	12,009 $854,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $1,525 - $1,679	21 Added 0.18%	12,008 $925,000
Q1 2022 May 04, 2022	SELL	$61.48 - $73.72 $1,659 - $1,990	-27 Reduced 0.22%	11,987 $875,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $281,074 - $327,667	5,241 Added 77.38%	12,014 $749,000
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $3,076 - $3,604	-52 Reduced 0.76%	6,773 $401,000
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $9,843 - $10,719	-159 Reduced 2.28%	6,825 $456,000
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $167,398 - $188,273	2,821 Added 67.76%	6,984 $441,000
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $686,470 - $777,897	-11,889 Reduced 74.07%	4,163 $258,000
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $13,323 - $14,764	232 Added 1.47%	16,052 $968,000
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $559,767 - $654,422	10,211 Added 182.05%	15,820 $930,000
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $57,953 - $84,220	-1,249 Reduced 18.21%	5,609 $312,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $337,482 - $440,215	6,858 New	6,858 $440,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $187,404 - $207,228	-4,200 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $189,504 - $225,960	4,200 New	4,200 $200,000

Others Institutions Holding BMY

# of Institutions

2,811

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $98.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.

Account

Slate Stone Wealth, LLC Bristol Myers Squibb CO Transaction History